This study aims to assess the magnitude and associated factors of poor medication adherence among patients with diabetes and hypertension visiting health facilities in Addis Ababa, Ethiopia, during the COVID-19 pandemic. A total of 409 patients were included in the study. Some 57% patients reported that the COVID-19 pandemic had a negative impact on their follow-up visits, availability of medicines or affordability. And 21% reported being affected in all aspects. The overall magnitude of poor medication adherence was 72%. More than three-quarters of patients participating in the study had poor adherence to diabetes and hypotensive medication. Type of healthcare facility, income level, comorbidities and history of substance use showed a statistically significant association with poor medication adherence. Stakeholders should identify alternative strategies, as the perceived impact of the COVID-19 pandemic on medication adherence is high in the study area.
Magnitude and associated factors of poor medication adherence among diabetic and hypertensive patients visiting public health facilities in Ethiopia during the COVID-19 pandemic
19 December 2022